Clinical Trials Logo

Clinical Trial Summary

This prospective observational study (registry) on Fragile X syndrome (FXS) is designed to evaluate characteristics, management and patient and caregiver-related outcomes the quality of life of Families and patients with FXS and to collect epidemiological and health economic data.

- EXPLAIN will report current and comprehensive data onEpidemiology data on fragile X syndrome

- Characterisation of the phenotype of FXS patients

- Description of patient characteristics (demographics, family history, comorbidity, education, working situations, care situations, insurance status)

- Documentation of therapeutic interventions

- Recording and assessment of psychosocial parameters (possibly also inclusion of family members, carers)

- quality of life of the carer and if possible the patient

- Health economic parameters and consumption of resources


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01711606
Study type Observational
Source Novartis
Contact
Status Terminated
Phase N/A
Start date March 2013
Completion date January 2016